about
Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forcesCXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemiaThe CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia.Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.Molecular and cellular mechanisms of CLL: novel therapeutic approaches.Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signalingCanonical and noncanonical Hedgehog/GLI signaling in hematological malignancies.Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanismsSmall peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model.Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.The sound of tumor cell-microenvironment communication - composed by the Cancer Cluster Salzburg research network.B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemiaCombined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors.Tiam1/Rac1 signals contribute to the proliferation and chemoresistance, but not motility, of chronic lymphocytic leukemia cells.Ibrutinib Inhibits VLA-4-Dependent Adhesion in CLL-Letter.Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.Regulation of sulphate assimilation by glutathione in poplars (Populus tremula x P. alba) of wild type and overexpressing gamma-glutamylcysteine synthetase in the cytosol.CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.Expression profiling of metabolic genes in response to methyl jasmonate reveals regulation of genes of primary and secondary sulfur-related pathways in Arabidopsis thaliana.TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.Methods for Investigating VLA-4 (CD49d/CD29) Expression and Activation in Chronic Lymphocytic Leukemia and Its Clinical ApplicationsCLL cells under flow
P50
Q28115946-C6D141E0-33C6-4C55-B356-A61DB15D1746Q30657004-E80B30A0-108A-4390-84A0-796CE8427A22Q33655756-FAE22082-9ED2-41E7-AE59-41E177AE48B0Q34432943-E9917E0F-D7D5-42DF-B6B3-1901CBB1BEEFQ35489417-6596C3B5-2CEC-447A-8B8F-0076F4FF0991Q35602348-1E835F68-AD15-4B01-AFEC-FF1D8F3B15CFQ36018118-AC713353-D46A-4F19-AB1A-7CCDD0872970Q37504699-6EECB862-C640-45CA-9E19-E2C73395B26FQ37593573-5166A90B-99AD-4D75-B652-BC57447AE01BQ37607838-A0C3992E-D816-496D-8E65-2DD1F9C7CC64Q37990679-538DC2E9-58BA-4AB0-9E6E-A60DB2041B97Q39658557-BDCDBBD0-D247-4982-9CD7-CF05B2A86B03Q39684126-E74789EA-3249-4918-B674-411E96431222Q39865621-4B7FBD8C-936A-4E34-A2CB-F352E4E2F340Q40420056-CCE94E9A-872A-4F71-A79E-72BBAC39812CQ40439589-E4247803-F34C-4B31-9491-E52C5207C3E1Q40469303-84E72470-77CF-4708-BAA8-18B3694DF053Q40808021-1C2D4A88-D07B-4C52-90D6-B5CB4ED026DAQ40928223-67CFB73E-B061-429A-B29A-A0069C711645Q42217233-DBDBF44B-5642-45B4-AE6A-823F924FFE99Q42330187-45CDE852-F734-4D70-9199-47D473769A98Q42342904-44170C93-12C5-4BF3-BC37-277F5AEE2B3CQ42399857-564794F4-CC2A-4F89-B0AF-9A5663EE5BDDQ42551543-2D1CDDF4-6F52-4688-BCAD-99E70C0CB187Q42742466-5BC2FF02-603E-4A99-8A55-B58DFFD7260CQ42807114-6E0F6D01-F1C0-4A80-B530-A3712CF17104Q44558291-526D8DED-87B1-46E1-8186-31AF0253EDEFQ44645796-5E1658A1-9E3A-44D3-8890-6AE230125056Q44799745-42BDDD83-052B-4437-9A39-B64845127A32Q45782254-76586ED9-A7C7-4ED3-AAE8-F800FC9B866AQ46085197-41D6CCF0-51D8-4FE6-93EC-5ADCB23B32E3Q46819546-0617A4B8-4E04-4981-9302-BBCDB5FF7E24Q47217185-E4E7C3DB-0FB2-446A-8EAB-0998D58066D3Q48307279-F2D2B476-07B2-4F1E-8C94-A20D5300CBF6Q49912101-042BBA6D-726C-42F9-AB33-75A847AF8829Q52373388-62C33813-AEDB-46F2-A97F-956DFFB4BF8DQ53032974-299D3FF6-C866-4E48-B89B-5B38FB88EED9Q53071978-30D28836-6ECA-4C18-9D14-B122D0595D4CQ57785223-86E936B4-8EFD-4C49-96B1-3446A00377BFQ58319749-D5AE7202-ECD0-4679-93D4-EF071BD9D368
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-0377-7179
@en
name
Tanja N Hartmann
@ast
Tanja N Hartmann
@en
Tanja N Hartmann
@es
Tanja N Hartmann
@nl
type
label
Tanja N Hartmann
@ast
Tanja N Hartmann
@en
Tanja N Hartmann
@es
Tanja N Hartmann
@nl
prefLabel
Tanja N Hartmann
@ast
Tanja N Hartmann
@en
Tanja N Hartmann
@es
Tanja N Hartmann
@nl
P106
P21
P214
8572149489123293810008
P31
P496
0000-0002-0377-7179
P734
P7859
viaf-8572149489123293810008